In September, the annual VALUE-Dx General Assembly took place in Barcelona. It was a fruitful meeting during which each work package gave an update on their work. High on the agenda were the sustainability of the project, health economic modelling and target product profiles. Insightful updates on the PRUDENCE and ADEQUATE clinical trials were also given, discussing cost effectiveness and process evaluation. It was a successful event filled with interesting exchanges and brainstorming about how to further improve collaborations. 

Next year in September, the VALUE-Dx Closing Conference will be held, marking the end of the project. During this event, the focus will mainly lie on the sustainability report, centered around the sustainability of the knowledge and valuable materials gained from the project. 

The meeting presentations and recordings will soon be available on the VALUE-Dx virtual learning platform.